Medlab Clinical Limited (ASX:MDC) shot up 2.9% during trading on Tuesday . The stock traded as high as A$0.36 ($0.26) and last traded at A$0.36 ($0.26), 61,962 shares changed hands during mid-day trading. The stock had previously closed at A$0.35 ($0.25).

The stock has a market cap of $72.15 million and a P/E ratio of -8.59. The company has a 50 day simple moving average of A$0.32 and a 200 day simple moving average of A$0.39. The company has a current ratio of 3.83, a quick ratio of 3.06 and a debt-to-equity ratio of 6.48.

Medlab Clinical Company Profile (ASX:MDC)

Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management.

See Also: How to Invest in an Index Fund

Receive News & Ratings for Medlab Clinical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medlab Clinical and related companies with MarketBeat.com's FREE daily email newsletter.